Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 540 | 1,075 | 721 | 852 | 1,346 |
| Cost of Goods | 653 | 60 | 35 | 147 | 669 |
| Gross Profit | -113 | 1,015 | 686 | 705 | 677 |
| Operating Expenses | 6,011 | 5,002 | 5,010 | 5,785 | 5,416 |
| Operating Income | -5,471 | -3,927 | -4,289 | -4,933 | -4,070 |
| Interest Expense | 334 | 331 | 327 | 327 | 650 |
| Other Income | 98 | 90 | 76 | 76 | 667 |
| Pre-tax Income | -5,707 | -4,168 | -4,540 | -5,184 | -4,053 |
| Income Tax | 1 | 7 | 11 | 6 | -196 |
| Net Income Continuous | -5,708 | -4,175 | -4,551 | -5,190 | -3,857 |
| Net Income | $-5,708 | $-4,175 | $-4,551 | $-5,190 | $-3,857 |
| EPS Basic Total Ops | -106.00 | -72.00 | -80.00 | -96.00 | 2,624.00 |
| EPS Basic Continuous Ops | -102.55 | -75.28 | -82.17 | -93.90 | 1,942.70 |
| EPS Diluted Total Ops | -106.00 | -72.00 | -80.00 | -96.00 | 2,624.00 |
| EPS Diluted Continuous Ops | -102.55 | -75.28 | -82.17 | -93.90 | 1,942.70 |
| EBITDA(a) | $-5,369 | $-3,871 | $-4,146 | $-4,790 | $-3,901 |